Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a chatbot tame gout? new trial puts AI diet coach to the test

NCT ID NCT07004231

Disease control Sponsor: SingHealth Polyclinics Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This trial tests an AI chatbot called Gout Buddy that gives personalized diet advice to people with gout. 110 participants will either use the chatbot or receive standard care. The goal is to see if the chatbot improves dietary knowledge, eating habits, medication adherence, and quality of life over 3-6 months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
AI chatbot (Gout Buddy)
What this could lead to
If it works, this could point toward a helpful digital tool that makes it easier for people with gout to understand and follow a healthy diet.
What could go wrong
This is a small, early-stage trial with only 110 participants, so results may not apply to everyone. The chatbot's effectiveness depends on user engagement and may not lead to lasting changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

110 people

The number who actually took part.

Started

Jul 2025

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age \> 21 years * At least one serum uric acid \> 360 μmol/L or an episode of acute gout attack within the last 18 months * Able to read and speak English * Access to an internet-enabled device compatible with Gout Buddy Exclusion Criteria: * Not a Singapore citizen or permanent resident * Pregnant * End-stage kidney disease or on renal replacement therapy * Known terminal illness * Visual and/or hearing impairment * Cognitive impairment or mental illness * Unable to provide informed consent * Individuals who do not have a personal mobile device with internet access

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Gout are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

gout

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Gout

Contacts and locations

Locations

  • SingHealth Polyclinics

    Singapore, Singapore

More trials for these conditions

Other studies related to the condition(s) this trial covers.